‌

US Patent 11260055 Oral pharmaceutical composition of lurasidone and preparation thereof

Patent 11260055 was granted and assigned to Piramal Enterprises on March, 2022 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Current Assignee

Piramal Enterprises

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

112600550

Patent Inventor Names

Tejas Shah0

Narendra Patel0

Vipan Dhall0

Umesh Barabde0

Devesh Bhatt0

Milan B. Agrawal0

Date of Patent

March 1, 2022

Patent Application Number

164763850

Date Filed

January 10, 2018

Patent Primary Examiner

‌

San Ming R Hui

Patent abstract

The present invention relates to an oral pharmaceutical composition, particularly a tablet, comprising an active ingredient lurasidone or its pharmaceutically acceptable salt(s) or solvate(s) thereof and one or more pharmaceutical excipient(s); and a process for its preparation.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11260055 Oral pharmaceutical composition of lurasidone and preparation thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API